BSBernhard Schwaab

Bernhard Schwaab

*This is an algorithmically generated author record based on publicly available information.

Bernhard Schwaab has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Telemedizin in der Rehabilitation nach Herzinfarkt

    by B. Schwaab

    After acute myocardial infarction, cardiac rehabilitation should be an essential part of any therapy aimed at long-term success. Telemedical studies have mostly investigated ECG-monitored exercise training at home and internet-based counseling for lifestyle modification in selected patients. This approach cannot replace the holistic and multidisciplinary approach of cardiac rehabilitation. Telemedicine should be further evaluated, however, as it offers significant opportunities to facilitate access to rehabilitation for those patients who would otherwise not be able to attend for geographical, logistic or psychosocial reasons.


  • Herz-Kreislauf-Patienten mit Diabetes mellitus Typ 2

    by B Schwaab, M Karoff, H Völler, A Wirth, T Witt

    Kardiologische Rehabilitation - Diabetes mellitus Typ 2 - Koronare Herzerkrankung - Lebensstil - Therapie - Prognose - Medikation cardiac rehabilitation - type 2 diabetes mellitus - coronary heart disease - lifestyle - therapy - prognosis - medication


  • In-patient cardiac rehabilitation versus medical care – a prospective multicentre controlled 12 months follow-up in patients with coronary heart disease

    by Bernhard Schwaab, Annika Waldmann, Alexander Katalinic, Abdolhamid Sheikhzadeh, Heiner Raspe

    Background: The aim of this study was to evaluate a 3-week inpatient cardiac rehabilitation (Rehab) started early after the index event in patients with coronary heart disease and evidence-based secondary preventive medication. Method: All patients had acute coronary angiography, 679 were discharged from hospital receiving usual care (Hosp), 795 completed a comprehensive Rehab. Follow-up was 12 months. Results: Rehab patients were older (64 vs. 62 years; p < 0.001), had more multivessel disease (51 vs. 37%; p < 0.001), heart failure (64 vs. 40%, p < 0.001), ST-segment elevation myocardial infarction (59 vs. 52%, p = 0.014), and renal insufficiency (10 vs. 7%, p = 0.036). Gender, peripheral artery disease, diabetes, hypertension, and socioeconomic status were similar in groups. Rehab patients had more beta-blockers (88 vs. 75%, p < 0.001) and angiotensin-converting enzyme inhibitors (81 vs. 70%, p < 0.001), a lower low-density lipoprotein cholesterol (102 vs. 122 mg/dl, p < 0.001), and a higher proportion of non-smokers (44 vs. 39%, p = 0.024). Primary combined endpoint of mortality, myocardial infarction (MI), revascularization, and hospitalization occurred in 32.6% of Rehab patients and in 38.7% of Hosp patients [p = 0.014; absolute risk reduction 0.0615, relative risk reduction 16%, number needed to treat (NNT) 17]. Myocardial infarction (MI) (1.8 vs. 3.8%, p = 0.015; NNT 49) and hospitalization (31.8 vs. 38.0%, p = 0.013; NNT 17) were reduced. In multivariate analysis, primary endpoint was reduced significantly (OR 0.729; 95% CI 0.585–0.909; p = 0.005) giving a relative risk reduction of 27% in favour of Rehab. Conclusion: Although Rehab patients were sicker at entry, their outcome was substantially improved within 12 months. With very low NNT, Rehab is highly effective and should be advised to all suitable patients with coronary heart disease.


  • Kardiovaskuläre Rehabilitation

    by B. Schwaab

    Die Ziele der kardiovaskulären Rehabilitation beinhalten neben der Optimierung der Sekundärprävention zur Reduktion von Morbidität und Mortalität auch die Verbesserung der körperlichen Leistungsfähigkeit und Lebensqualität sowie die Wiedereingliederung in das soziale und Erwerbsleben. Dazu sind multimodale Interventionen auf somatischer, psychologischer, edukativer sowie sozialer Ebene durch ein interdisziplinäres Team erforderlich. In 4 aktuellen deutschen Kohortenstudien konnte die stationäre Anschlussheilbehandlung bei 10.758 Patienten mit akutem Myokardinfarkt und nach Bypassoperation die Gesamtmortalität, Reinfarktrate und Hospitalisierung im Verlauf von 1–2 Jahren signifikant reduzieren. Diese Ereignisreduktion gelang zusätzlich zu einer interventionellen Akuttherapie und einer evidenzbasierten medikamentösen chronischen Therapie. Eine kardiovaskuläre Rehabilitation wird von den nationalen und internationalen Fachgesellschaften darüber hinaus empfohlen für Patienten nach dekompensierter Herzinsuffizienz, nach Herzklappenersatz und -rekonstruktion, nach Herztransplantation und nach Implantation eines Kardioverter/Defibrillators. In Zukunft sollte die Evidenz der kardiologischen Rehabilitation in Deutschland durch randomisierte kontrollierte Studien gesichert und die multimodalen Interventionen noch individueller auf spezifische Patientengruppen und Indikationen ausgerichtet werden. Cardiovascular rehabilitation encompasses the optimization of secondary prevention to reduce morbidity and mortality, the improvement of physical fitness and quality of life as well as the reintegration into social life and employment. This requires a multifactorial intervention on the physical, psychological, educative and social level by a multidisciplinary team. In Germany, cardiac rehabilitation started early after an index event, could demonstrate a significant reduction of total mortality, myocardial infarction and hospitalization during a follow-up of 1–2 years in 4 cohort studies including 10.758 patients with myocardial infarction and bypass surgery. This reduction of clinical events was obtained in addition to rapid revascularization therapy during the acute coronary event and on top of an evidence based secondary preventive medication. By national and international medical societies, cardiac rehabilitation is recommended as well in patients with congestive heart failure, after valve replacement or valve repair, after heart transplantation and cardioverter/defibrillator implantation. In the future, cardiac rehabilitation in Germany should be evaluated by a randomized controlled trial and multifactorial interventions should be tailored individually to specific patient subgroups and medical conditions.